Cellosaurus HG2L6.1c3 (CVCL_DC31)
Cell line name | HG2L6.1c3 |
---|---|
Accession | CVCL_DC31 |
Resource Identification Initiative | To cite this cell line use: HG2L6.1c3 (RRID:CVCL_DC31) |
Comments | Population: Caucasian. Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists. Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Firefly luciferase. Derived from site: In situ; Liver; UBERON=UBERON_0002107. |
Sequence variations |
|
Disease | Hepatoblastoma (NCIt: C3728) Hepatoblastoma (ORDO: Orphanet_449) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_0027 (Hep-G2) |
Sex of cell | Male |
Age at sampling | 15Y |
Category | Cancer cell line |
Publications | PubMed=21394221; DOI=10.1007/s11426-010-0142-8; PMCID=PMC3049243 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_DC31 |
Encyclopedic resources | Wikidata; Q54885926 |
Entry history | |
Entry creation | 13-Jul-2016 |
Last entry update | 10-Sep-2024 |
Version number | 17 |